Education and experience:
Mr Liberti is the Executive Director of CIRS (the Centre for Innovation in Regulatory Science, Ltd. He is a pharmacist with a master’s degree in pharmacognosy (both from the Philadelphia College of Pharmacy and Science) and is pursuing the PhD in International Regulatory Policy through the WHO Collaborating Centre for Pharmaceutical Policy and Regulation based in the Utrecht Institute for Pharmaceutical Sciences, Utrecht University, the Netherlands. He is researching expedited regulatory pathways with applicability in the Emerging Markets. He was awarded the status of Regulatory Affairs Certified (RAC) by the Regulatory Affairs Professional Society and an honorary Doctor of Science by the University of the Sciences in Philadelphia. He is a Fellow of the American Medical Writers Association and is a recipient of their Golden Apple award for excellence in teaching. For the past 38 years, Mr Liberti has worked in and with the pharmaceutical industry, in the fields of regulatory affairs and clinical R&D. He began his career at Wyeth Laboratories then served as the Editorial Director for ADIS international after which he founded PIA Ltd, a company specializing in regulatory writing and consulting.
Former PhD project:
Characterising a globally applicable Facilitated Regulatory Pathway (FRP) as a policy to streamline medicines reviews and improve worldwide access to critical medicines
Team members and other people involved:
Centre for Innovation in Regulatory Science, Ltd, UU WHO collaborating centre for Pharmaceutical Policy and Regulation